Viewing Study NCT06910592

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:58 PM
Ignite Modification Date: 2026-01-31 @ 10:56 PM
Study NCT ID: NCT06910592
Status: COMPLETED
Last Update Posted: 2025-09-17
First Post: 2025-03-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: EXOMIND (BTL-995) for Reduction of Binge-eating
Sponsor: BTL Industries Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Binge-Eating Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None binge-eating View
None overeating View
None weight loss View
None ExoTMS View
None EXOMIND View